Core Viewpoint - Royal Unibrew's Q3 '25 Trading Statement highlights solid financial performance driven by strategic execution and margin expansion, with a focus on attractive beverage categories [3]. Financial Performance - The company achieved organic revenue growth of over 3% in the first nine months of '25, outperforming European peers despite low consumer confidence [3]. - 60% of net revenue is derived from growing beverage categories, including no/low sugar, carbonated soft drinks, energy drinks, enhanced ready-to-drink (RTD) beverages, cider, and premium products [3]. Strategic Progress - The growth framework implemented by the company is yielding positive results, indicating that the strategic approach is effective [3]. - New activities in the BeLux market contributed to top-line growth, although there were also negative impacts noted [4].

Core Viewpoint - Ambev S.A. is recognized as one of the most profitable penny stocks to consider, with upcoming earnings expectations indicating potential growth despite recent challenges in revenue and volume [1]. Financial Performance - In Q2 FY2025, Ambev reported revenue of $3.59 billion, which was $250.95 million below consensus estimates, but represented a year-over-year increase of 2.65% [2]. - The adjusted earnings per share for Q2 FY2025 were $0.03, aligning with market expectations [2]. - The company experienced a 4.5% decline in total organic volumes compared to the previous year, attributed to industry softness [2]. - Despite the volume decline, Ambev achieved a 15% increase in net income, and EBITDA grew by high single digits, with a margin expansion of 110 basis points [2]. Market Expectations - Ambev is set to report its Q3 2025 earnings on October 30, 2025, with Wall Street anticipating adjusted earnings per share of $0.04 and revenue around $4.24 billion [1]. - Following the Q2 results, UBS maintained a Hold rating on Ambev, lowering the price target from $2.5 to $2.2, while Evercore ISI assigned a Buy rating with a price target of $4 [3]. - As of September 16, the average price target for Ambev was $2.81, suggesting an upside potential of approximately 19.03% from current levels [3]. Company Overview - Ambev S.A. is a Brazil-based brewer involved in the production, distribution, and sale of various beverages, including beer, draft beer, carbonated soft drinks, and other alcoholic and non-alcoholic drinks [4].

Group 1 - Keurig Dr Pepper Inc. announced an acquisition of JDE Peet's in an all-cash deal valued at approximately $18 billion, aiming to enhance its single-serve coffee platform with JDE Peet's global coffee brand portfolio [1] - Post-acquisition, the company plans to split into two independent publicly listed entities: Beverage Co., focusing on North American refreshment beverages, and Global Coffee Co., which will be the largest pure-play coffee company globally [2] - The acquisition terms include a payment of €31.85 per share to JDE Peet's shareholders, representing a 33% premium over its 90-day average stock price, with expected cost savings of around $400 million over three years [3] Group 2 - Keurig Dr Pepper Inc. is a significant player in the North American beverage market, producing a diverse range of hot and cold beverages, including carbonated soft drinks, juices, teas, and specialty coffee [4]